Sorrento Therapeutics Inc. shareholders urged a court to hold off on approving millions of dollars in fees the drug developer’s attorneys charged while an appeal related to the judge who previously oversaw its bankruptcy is pending.
A committee of equity holders lost a bid in December to look into communications and documents that allegedly showed a conflict of interest between former Jackson Walker LLP attorney Elizabeth Freeman, former US Bankruptcy Court for the Southern District of Texas Judge David R. Jones, and other Sorrento advisers.
Until a decision is made regarding the appeal, “no compensation should be payable to any ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.